DNA origami could be used to create customized virus-like particles

FHS
July 17, 2023
7:06 pm

Bioengineers have found a way to program the size and shape of virus particles by combining viral protein building blocks and templates made from DNA.

The importance of reducing the financial burden of participating in clinical trials

Scientific advancements have helped millions of people living with cancer, heart disease, arthritis, obesity, and other diseases. Essential for the development of new therapies are

August 27, 2024

Looking to expand its pipeline, Merck to buy eye-disease startup EyeBio

LONDON — Merck said Wednesday it is buying ophthalmology-focused startup EyeBio in a deal worth up to $3 billion, as the pharma company looks to

May 29, 2024

FDA delays assessment of BMS and 2seventy’s CAR-T therapy

Share this article Abecma was approved as a fifth-line therapy for relapsed or refractory multiple myeloma by the FDA in 2021. Image Credit: JHVEPhoto /

November 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.